190 related articles for article (PubMed ID: 27191272)
1. The tumor suppressive miR-200b subfamily is an ERG target gene in human prostate tumors.
Zhang Z; Lanz RB; Xiao L; Wang L; Hartig SM; Ittmann MM; Feng Q; He B
Oncotarget; 2016 Jun; 7(25):37993-38003. PubMed ID: 27191272
[TBL] [Abstract][Full Text] [Related]
2. The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker.
Xiao L; Lanz RB; Frolov A; Castro PD; Zhang Z; Dong B; Xue W; Jung SY; Lydon JP; Edwards DP; Mancini MA; Feng Q; Ittmann MM; He B
Prostate; 2016 Oct; 76(14):1271-84. PubMed ID: 27272765
[TBL] [Abstract][Full Text] [Related]
3. TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c.
Kim J; Wu L; Zhao JC; Jin HJ; Yu J
Oncogene; 2014 Oct; 33(44):5183-92. PubMed ID: 24186205
[TBL] [Abstract][Full Text] [Related]
4. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.
Kao CJ; Martiniez A; Shi XB; Yang J; Evans CP; Dobi A; deVere White RW; Kung HJ
Oncogene; 2014 May; 33(19):2495-503. PubMed ID: 23728339
[TBL] [Abstract][Full Text] [Related]
5. MiR-1271 Inhibits Cell Growth in Prostate Cancer by Targeting ERG.
Wang M; Gao W; Lu D; Teng L
Pathol Oncol Res; 2018 Apr; 24(2):385-391. PubMed ID: 28551819
[TBL] [Abstract][Full Text] [Related]
6. miR-4482 and miR-3912 aim for 3'UTR of ERG mRNA in prostate cancer.
Mumtaz S; Usman Rashid M; Khan RU; Malkani N
PLoS One; 2023; 18(6):e0286996. PubMed ID: 37310937
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin.
Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M
Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963
[TBL] [Abstract][Full Text] [Related]
8. Role of the TMPRSS2-ERG gene fusion in prostate cancer.
Tomlins SA; Laxman B; Varambally S; Cao X; Yu J; Helgeson BE; Cao Q; Prensner JR; Rubin MA; Shah RB; Mehra R; Chinnaiyan AM
Neoplasia; 2008 Feb; 10(2):177-88. PubMed ID: 18283340
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of PRKAR2B by miR-200b-3p/200c-3p and XBP1 in human prostate cancer.
Xia L; Han Q; Chi C; Zhu Y; Pan J; Dong B; Huang Y; Xia W; Xue W; Sha J
Biomed Pharmacother; 2020 Apr; 124():109863. PubMed ID: 31986411
[TBL] [Abstract][Full Text] [Related]
10. Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1.
Kumar P; Sharad S; Petrovics G; Mohamed A; Dobi A; Sreenath TL; Srivastava S; Biswas R
Oncotarget; 2016 Apr; 7(16):22791-806. PubMed ID: 26988912
[TBL] [Abstract][Full Text] [Related]
11. Significance of the TMPRSS2:ERG gene fusion in prostate cancer.
Wang Z; Wang Y; Zhang J; Hu Q; Zhi F; Zhang S; Mao D; Zhang Y; Liang H
Mol Med Rep; 2017 Oct; 16(4):5450-5458. PubMed ID: 28849022
[TBL] [Abstract][Full Text] [Related]
12. Decreased miR-200b-3p in cancer cells leads to angiogenesis in HCC by enhancing endothelial ERG expression.
Moh-Moh-Aung A; Fujisawa M; Ito S; Katayama H; Ohara T; Ota Y; Yoshimura T; Matsukawa A
Sci Rep; 2020 Jun; 10(1):10418. PubMed ID: 32591615
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
15. miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer.
Gordanpour A; Stanimirovic A; Nam RK; Moreno CS; Sherman C; Sugar L; Seth A
Anticancer Res; 2011 Feb; 31(2):403-10. PubMed ID: 21378318
[TBL] [Abstract][Full Text] [Related]
16. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
[TBL] [Abstract][Full Text] [Related]
18. The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer.
Hart M; Wach S; Nolte E; Szczyrba J; Menon R; Taubert H; Hartmann A; Stoehr R; Wieland W; Grässer FA; Wullich B
FEBS J; 2013 May; 280(9):2105-16. PubMed ID: 23480797
[TBL] [Abstract][Full Text] [Related]
19. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
Jin W; Fei X; Wang X; Chen F; Song Y
J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
[TBL] [Abstract][Full Text] [Related]
20. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.
Cai C; Wang H; He HH; Chen S; He L; Ma F; Mucci L; Wang Q; Fiore C; Sowalsky AG; Loda M; Liu XS; Brown M; Balk SP; Yuan X
J Clin Invest; 2013 Mar; 123(3):1109-22. PubMed ID: 23426182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
